by Jacob Schor, ND, FABNO
An Iranian double-blind randomized controlled trial compared the effectiveness of 3 treatments for reducing severity of persistent coughs that follow upper respiratory infections (the treatment groups were the honey-coffee group, steroid group, and control [guaifenesin] group). The decrease in cough frequency for the honey-coffee group was statistically significant and significantly greater than in the steroid or control groups.
by Michael Traub, ND, DHANP, FABNO
A 20-year follow-up study based on the Melanoma in Southern Sweden study concluded that all-cause mortality was inversely related to sun-exposure habits—but why do the authors not consider vitamin D supplementation, which is proven to enrich the body while not causing skin cancers?
by Kirsten West, ND, LAc, FABNO
In this randomized, double-blind, placebo-controlled clinical trial, participants were randomized to receive either curcuminoids (curcumin) or matched placebo for 8 week. The curcumin group demonstrated improvement in biomarkers and quality of life measures, but more studies are needed to prove curcumin’s efficacy as an adjunct to chemotherapy.
by William Benda, MD
In a recent study involving Alzheimer's patients, horse therapy improved behavior and stress measures. This research echoes existing literature about how animals can help dementia sufferers.
by Jacob Schor, ND, FABNO
Using diseased carotid artery samples from 15 patients, the authors of this study found eubacterial rRNA hiding in the arterial tissue, bacteria that may trigger heart disease. This finding represents the beginning of a paradigm shift in how clinicians view bacteria, biofilms, and cardiovascular disease.
by Angela Senders, ND, MCR
The ability to access, interpret, and critically evaluate primary medical literature—is a skill natural medicine practitioners must develop to better educate their patients and promote their profession.
by Todd A. Born, ND
Nonalcoholic fatty liver disease (NAFLD) is subdivided into nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). In the United States, prevalence of NAFLD is 10% to 46% of the population. Worldwide prevalence is 6% to 35% (median 20%). There is a need to increase understanding of liver disease and its many causes, which will help to improve patient outcomes and reduce the stigma many patients experience. This article discusses epidemiology, etiologies, suspected pathogenesis, and risk factors, along with conventional and naturopathic therapeutic treatment options.
by Tina Kaczor, ND, FABNO
Michael Friedman, ND, founder and executive director of the Association for the Advancement of Restorative Medicine (AARM), talks to Natural Medicine Journal about the history of this collaborative organization, its publication the Journal of Restorative Medicine, and its conference coming up in October 2014.